A quarter of all solid tumors harbor KRAS oncogenes. Yet, no selective drugs have been approved to treat these malignancies. Genetic interrogation of the MAPK pathway revealed that systemic ablation of MEK or ERK kinases in adult mice prevent tumor development but are unacceptably toxic. Here, we demonstrate that ablation of c-RAF expression in advanced tumors driven by KrasG12V/Trp53 mutations leads to significant tumor regression with no detectable appearance of resistance mechanisms. Tumor regression results from massive apoptosis. Importantly, systemic abrogation of c-RAF expression does not inhibit canonical MAPK signaling, hence, resulting in limited toxicities. These results are of significant relevance for the design of therapeutic strategies to treat K-RAS mutant cancers.
Pubmed ID: 29395869 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets RAT ANTI MOUSE F4/80
View all literature mentionsThis monoclonal targets Vinculin antibody produced in mouse
View all literature mentionsThis monoclonal targets GAPDH antibody produced in mouse
View all literature mentionsThis polyclonal targets CD8A
View all literature mentionsThis polyclonal targets CD3E
View all literature mentionsThis polyclonal targets CFL1
View all literature mentionsThis polyclonal targets Cleaved Caspase-3 (Asp175)
View all literature mentionsThis polyclonal targets Caspase-3
View all literature mentionsThis monoclonal targets Pan-Ras
View all literature mentionsThis monoclonal targets Phospho-Akt (Ser473)
View all literature mentionsThis polyclonal targets Erk1/2
View all literature mentionsThis monoclonal targets ERK2
View all literature mentionsThis monoclonal targets Phospho-MEK1/2 (Ser217/221)
View all literature mentionsThis monoclonal targets c-Raf-1
View all literature mentionsThis monoclonal targets Raf-B (F-7)
View all literature mentionsMus musculus with name 129-Braftm1Sva/J from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Ndor1Tg(UBC-cre/ERT2)1Ejb/1J from IMSR.
View all literature mentionsMus musculus with name B6;129-Trp53tm1.1Dgk/J from IMSR.
View all literature mentionsMus musculus with name B6.129-Krastm3Bbd/J from IMSR.
View all literature mentionsStatistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.
View all literature mentions